XATRAL 2.5 MG

Country: Israel

Language: English

Source: Ministry of Health

Buy It Now

Active ingredient:

ALFUZOSIN HYDROCHLORIDE 2.5 MG

Available from:

SANOFI - AVENTIS ISRAEL LTD

ATC code:

G04CA01

Pharmaceutical form:

TABLETS

Administration route:

PER OS

Manufactured by:

SANOFI WINTHROP IND., FRANCE

Therapeutic group:

ALFUZOSIN

Therapeutic indications:

Treatment of certain functional symptoms of benign prostatic hypertrophy, notably when surgery has to be delayed for whaterver reason and during episodes of severe symptoms of adenoma, especially in elderly patients.

Authorization date:

2008-12-01

Search alerts related to this product

View documents history